Teva Pharmaceuticals and Sanofi have announced new results from an ongoing trial of an experimental medicine called duvakitug, used in people with moderate to severe ulcerative colitis or Crohn’s disease. The companies reported that improvements seen earlier in the study were still present after 44 weeks of treatment. The findings may be relevant to people […]
For many people living with inflammatory bowel disease (IBD), the idea of cycling to work sounds less like a healthy habit and more like a logistical risk. The worry is rarely about fitness, it is about finding a toilet in time. With some planning and a better understanding of what is actually happening in the […]
Many people living with inflammatory bowel disease (IBD) have had the experience of looking “fine” on the outside while managing pain, fatigue, or urgent bathroom trips underneath a composed exterior. Disability Pride Month, marked each July, offers a chance to talk openly about conditions like Crohn’s disease and ulcerative colitis as genuine disabilities, even when […]
AbbVie has presented early-stage data suggesting that ABBV-466, an investigational dual-targeting therapy, achieved higher rates of endoscopic remission in people with moderate to severe Crohn’s disease than either of the single-pathway treatments it was compared against. The findings, disclosed by AbbVie, point to a potential new option for patients whose disease does not respond adequately […]
Many people with inflammatory bowel disease (IBD) notice that a can of fizzy drink, a sugary snack, or a large portion of certain fruits seems to trigger bloating or discomfort more than other foods do. Part of the explanation may lie not in “sugar” as a single category, but in the specific type of sugar […]
Many people living with Crohn’s disease or ulcerative colitis, the two main forms of inflammatory bowel disease (IBD, a group of conditions causing long-term inflammation of the digestive tract), notice that sugary foods seem to coincide with flares or digestive discomfort. This has fuelled interest in whether sugar itself drives gut inflammation, or whether the […]
Eli Lilly has reported findings from two late-stage clinical trials, LUCENT-2 and VIVID-1, suggesting that its interleukin-23 (IL-23) inhibitor mirikizumab, marketed as Omvoh, offers benefits across multiple aspects of disease control in both ulcerative colitis (UC) and Crohn’s disease (CD). The results point to a treatment approach that extends beyond standard remission measures to address […]
Most people rarely think about what is normal for their own bowel movements until something changes. Doctors say certain shifts in colour, texture or frequency can be an early sign that something needs medical attention, while others are harmless and linked to diet or medicines. Understanding the difference may help people with digestive symptoms know […]
Many people with Crohn’s disease or ulcerative colitis suspect certain foods unsettle their gut, and sugar is often top of that list. Biscuits, fizzy drinks, and sweetened cereals get blamed for everything from bloating to flares, yet the real relationship between sugar and gut inflammation is more nuanced than “sugar is bad”. Understanding what actually […]
Many people with inflammatory bowel disease (IBD) try cutting carbohydrates to ease bloating, loose stools, or discomfort. It often brings short-term relief, making it tempting to stick with long term. But there is a trade-off happening quietly in the background: the bacteria that help keep your gut lining healthy rely on carbohydrate, specifically fibre, as […]
Ready to take control of your gut health?
Join for Free